ReP USP - Resultado da busca

Artigo de periodico
Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health REACH) Registry (2016)
Eisen, Alon; Bhatt, Deepak L.; Steg, Gabriel; Eagle, Kim A.; Goto, Shinya; Guo, Jianping; Smith, Sidney C.; Ohman, E. Magnus; Scirica, Benjamin; Maciel, Léa Maria Zanini; Pazin Filho, Antonio
Source: Journal of the American Heart Association - JAHA. Unidade: FMRP
Subjects: ANGINA PECTORIS, DOENÇAS CARDIOVASCULARES, CORONARIOPATIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EISEN, Alon et al. Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health REACH) Registry. Journal of the American Heart Association - JAHA, v. 5, n. 10, 2016Tradução . . Disponível em: https://doi.org/10.1161/JAHA.116.004080. Acesso em: 19 nov. 2024.
APA
Eisen, A., Bhatt, D. L., Steg, G., Eagle, K. A., Goto, S., Guo, J., et al. (2016). Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health REACH) Registry. Journal of the American Heart Association - JAHA, 5( 10). doi:10.1161/JAHA.116.004080
NLM
Eisen A, Bhatt DL, Steg G, Eagle KA, Goto S, Guo J, Smith SC, Ohman EM, Scirica B, Maciel LMZ, Pazin Filho A. Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health REACH) Registry [Internet]. Journal of the American Heart Association - JAHA. 2016 ; 5( 10):[citado 2024 nov. 19 ] Available from: https://doi.org/10.1161/JAHA.116.004080
Vancouver
Eisen A, Bhatt DL, Steg G, Eagle KA, Goto S, Guo J, Smith SC, Ohman EM, Scirica B, Maciel LMZ, Pazin Filho A. Angina and future cardiovascular events in stable patients with coronary artery disease: Insights from the Reduction of Atherothrombosis for Continued Health REACH) Registry [Internet]. Journal of the American Heart Association - JAHA. 2016 ; 5( 10):[citado 2024 nov. 19 ] Available from: https://doi.org/10.1161/JAHA.116.004080
Artigo de periodico
Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer (2015)
Wei, Shuo; Kozono, Shingo; Kats, Lev; Nechama, Morris; Li, Wenzong; Guarnerio, Jlenia; Luo, Manli; You, Mi-Hyeon; Yao, Yandan; Kondo, Asami; Hu, Hai; Bozkurt, Gunes; Moerke, Nathan; Cao, Shungeng; Reschke, Markus; Chen, Chun-Hau; Rego, Eduardo Magalhães; Lo-Coco, Francesco; Cantley, Lewis C.; Lee, Tae Ho; Wu, Hao; Pandolfi, Pier Paolo; Zhou, Xiao Zhen; Lu, Kun Ping
Source: Nature Medicine. Unidade: FMRP
Subjects: LEUCEMIA MIELOIDE AGUDA, FOSFATOS, CATÁLISE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
WEI, Shuo et al. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer. Nature Medicine, v. 21, n. 5, p. 457-466, 2015Tradução . . Disponível em: https://doi.org/10.1038/nm.3839. Acesso em: 19 nov. 2024.
APA
Wei, S., Kozono, S., Kats, L., Nechama, M., Li, W., Guarnerio, J., et al. (2015). Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer. Nature Medicine, 21( 5), 457-466. doi:10.1038/nm.3839
NLM
Wei S, Kozono S, Kats L, Nechama M, Li W, Guarnerio J, Luo M, You M-H, Yao Y, Kondo A, Hu H, Bozkurt G, Moerke N, Cao S, Reschke M, Chen C-H, Rego EM, Lo-Coco F, Cantley LC, Lee TH, Wu H, Pandolfi PP, Zhou XZ, Lu KP. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer [Internet]. Nature Medicine. 2015 ; 21( 5): 457-466.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1038/nm.3839
Vancouver
Wei S, Kozono S, Kats L, Nechama M, Li W, Guarnerio J, Luo M, You M-H, Yao Y, Kondo A, Hu H, Bozkurt G, Moerke N, Cao S, Reschke M, Chen C-H, Rego EM, Lo-Coco F, Cantley LC, Lee TH, Wu H, Pandolfi PP, Zhou XZ, Lu KP. Active Pin1 is a key target of all-trans retinoic acid in acute promyelocytic leukemia and breast cancer [Internet]. Nature Medicine. 2015 ; 21( 5): 457-466.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1038/nm.3839
Artigo de periodico
All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies (2015)
Sanz, Miguel A.; Montesinos, Pau; Kim, Haesook T.; Ruiz-Argüelles, Guillermo J.; Undurraga, María S.; Uriarte, María R.; Martínez, Lem; Jacomo, Rafael H.; Gutiérrez-Aguirre, Homero; Melo, Raul A. M.; Bittencourt, Rosane; Pasquini, Ricardo; Pagnano, Katia; Fagundes, Evandro M.; Vallenga, Edo; Holowiecka, Alexandra; González-Huerta, Ana J.; Fernández, Pascual; De La Serna, Javier; Brunet, Salut; De Lisa, Elena; González-Campos, José; Ribera, José M.; Krsnik, Isabel; Ganser, Arnold; Berliner, Nancy; Ribeiro, Raul C.; Lo-Coco, Francesco; Löwenberg, Bob; Rego, Eduardo Magalhães
Source: Annals of Hematology. Unidade: FMRP
Subjects: LEUCEMIA, VITAMINA A, QUIMIOTERÁPICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SANZ, Miguel A. et al. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies. Annals of Hematology, v. 94, n. 8, p. 1347-1356, 2015Tradução . . Disponível em: https://doi.org/10.1007/s00277-015-2393-0. Acesso em: 19 nov. 2024.
APA
Sanz, M. A., Montesinos, P., Kim, H. T., Ruiz-Argüelles, G. J., Undurraga, M. S., Uriarte, M. R., et al. (2015). All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies. Annals of Hematology, 94( 8), 1347-1356. doi:10.1007/s00277-015-2393-0
NLM
Sanz MA, Montesinos P, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte MR, Martínez L, Jacomo RH, Gutiérrez-Aguirre H, Melo RAM, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Vallenga E, Holowiecka A, González-Huerta AJ, Fernández P, De La Serna J, Brunet S, De Lisa E, González-Campos J, Ribera JM, Krsnik I, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Rego EM. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies [Internet]. Annals of Hematology. 2015 ; 94( 8): 1347-1356.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1007/s00277-015-2393-0
Vancouver
Sanz MA, Montesinos P, Kim HT, Ruiz-Argüelles GJ, Undurraga MS, Uriarte MR, Martínez L, Jacomo RH, Gutiérrez-Aguirre H, Melo RAM, Bittencourt R, Pasquini R, Pagnano K, Fagundes EM, Vallenga E, Holowiecka A, González-Huerta AJ, Fernández P, De La Serna J, Brunet S, De Lisa E, González-Campos J, Ribera JM, Krsnik I, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Rego EM. All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies [Internet]. Annals of Hematology. 2015 ; 94( 8): 1347-1356.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1007/s00277-015-2393-0
Artigo de periodico
Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors (2013)
Barthélémy, Olivier; Limbourg, Tobias; Collet, Jean Philippe; Beygui, Farzin; Silvain, Johanne; Bellemain-Appaix, Anne; Cayla, Guillaume; Chastre, Thomas; Baumgartner, Iris; Röther, Joachim; Zeymer, Uwe; Bhatt, Deepak L.; Steg, Gabriel; Montalescot, Gilles; Pazin Filho, Antonio; Maciel, Léa Maria Zanini
Source: International Journal of Cardiology. Unidade: FMRP
Subjects: ANTI-INFLAMATÓRIOS NÃO ESTEROIDES, INFARTO DO MIOCÁRDIO, ACIDENTE VASCULAR CEREBRAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BARTHÉLÉMY, Olivier et al. Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors. International Journal of Cardiology, v. 163, n. 3, p. 266-271, 2013Tradução . . Disponível em: https://doi.org/10.1016/j.ijcard.2011.06.015. Acesso em: 19 nov. 2024.
APA
Barthélémy, O., Limbourg, T., Collet, J. P., Beygui, F., Silvain, J., Bellemain-Appaix, A., et al. (2013). Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors. International Journal of Cardiology, 163( 3), 266-271. doi:10.1016/j.ijcard.2011.06.015
NLM
Barthélémy O, Limbourg T, Collet JP, Beygui F, Silvain J, Bellemain-Appaix A, Cayla G, Chastre T, Baumgartner I, Röther J, Zeymer U, Bhatt DL, Steg G, Montalescot G, Pazin Filho A, Maciel LMZ. Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors [Internet]. International Journal of Cardiology. 2013 ; 163( 3): 266-271.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.ijcard.2011.06.015
Vancouver
Barthélémy O, Limbourg T, Collet JP, Beygui F, Silvain J, Bellemain-Appaix A, Cayla G, Chastre T, Baumgartner I, Röther J, Zeymer U, Bhatt DL, Steg G, Montalescot G, Pazin Filho A, Maciel LMZ. Impact of non-steroidal anti-inflammatory drugs (NSAIDs) on cardiovascular outcomes in patients with stable atherothrombosis or multiple risk factors [Internet]. International Journal of Cardiology. 2013 ; 163( 3): 266-271.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.ijcard.2011.06.015
Artigo de periodico
Identification of myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia (2009)
Guibal, Florence C.; Alberich-Jorda, Meritxell; Hirai, Hideyo; Ebralidze, Alexander; Levantini, Elena; Di Ruscio, Annalisa; Zhang, Pu; Santana-Lemos, Barbara A. A; Neuberg, Donna; Wagers, Amy J.; Rego, Eduardo Magalhaes; Tenen, Daniel G.
Source: Blood. Unidade: FMRP
Subjects: HEMATOLOGIA, LEUCEMIA, CÉLULAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUIBAL, Florence C. et al. Identification of myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood, v. 114, n. 27, p. 5415-5425, 2009Tradução . . Disponível em: https://doi.org/10.1182/blood-2008-10-182071. Acesso em: 19 nov. 2024.
APA
Guibal, F. C., Alberich-Jorda, M., Hirai, H., Ebralidze, A., Levantini, E., Di Ruscio, A., et al. (2009). Identification of myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia. Blood, 114( 27), 5415-5425. doi:10.1182/blood-2008-10-182071
NLM
Guibal FC, Alberich-Jorda M, Hirai H, Ebralidze A, Levantini E, Di Ruscio A, Zhang P, Santana-Lemos BAA, Neuberg D, Wagers AJ, Rego EM, Tenen DG. Identification of myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia [Internet]. Blood. 2009 ; 114( 27): 5415-5425.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1182/blood-2008-10-182071
Vancouver
Guibal FC, Alberich-Jorda M, Hirai H, Ebralidze A, Levantini E, Di Ruscio A, Zhang P, Santana-Lemos BAA, Neuberg D, Wagers AJ, Rego EM, Tenen DG. Identification of myeloid committed progenitor as the cancer-initiating cell in acute promyelocytic leukemia [Internet]. Blood. 2009 ; 114( 27): 5415-5425.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1182/blood-2008-10-182071
Artigo de periodico
Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry (2009)
Cacoub, Patrice P.; Abola, Maria Teresa B.; Baumgartner, Iris; Bhatt, Deepak L.; Creager, Mark A.; Liau, Chiau-Suong; Goto, Shinya; Röther, Joachim; Steg, P. Gabriel; Hirsch, Alan T.; Maciel, Léa Maria Zanini; Pazin Filho, Antonio
Source: Atherosclerosis. Unidade: FMRP
Subjects: FATORES DE RISCO, DOENÇAS VASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CACOUB, Patrice P. et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis, v. 204, n. 2, p. e86-e92, 2009Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2008.10.023. Acesso em: 19 nov. 2024.
APA
Cacoub, P. P., Abola, M. T. B., Baumgartner, I., Bhatt, D. L., Creager, M. A., Liau, C. -S., et al. (2009). Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Atherosclerosis, 204( 2), e86-e92. doi:10.1016/j.atherosclerosis.2008.10.023
NLM
Cacoub PP, Abola MTB, Baumgartner I, Bhatt DL, Creager MA, Liau C-S, Goto S, Röther J, Steg PG, Hirsch AT, Maciel LMZ, Pazin Filho A. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry [Internet]. Atherosclerosis. 2009 ; 204( 2): e86-e92.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2008.10.023
Vancouver
Cacoub PP, Abola MTB, Baumgartner I, Bhatt DL, Creager MA, Liau C-S, Goto S, Röther J, Steg PG, Hirsch AT, Maciel LMZ, Pazin Filho A. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry [Internet]. Atherosclerosis. 2009 ; 204( 2): e86-e92.[citado 2024 nov. 19 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2008.10.023

USP Schools

ReP

Filtros

Authors

Subjects

Source title

Indexado em

Non normalized affiliation

Countries of institutions of collaboration